MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP

被引:21
作者
Cao, Zhe [1 ,2 ]
Xu, Jianwei [1 ,2 ]
Huang, Hua [1 ,2 ]
Shen, Peng [1 ,2 ]
You, Lei [1 ,2 ]
Zhou, Li [1 ,2 ]
Zheng, Lianfang [2 ,3 ]
Zhang, Taiping [1 ,2 ]
Zhao, Yupei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 01期
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
HSC70-INTERACTING PROTEIN; INDUCED DEGRADATION; TUMOR-SUPPRESSOR; C-TERMINUS; MUTANT P53; CARCINOMA; CHAPERONE; GROWTH; ADENOCARCINOMA; INACTIVATION;
D O I
10.1371/journal.pone.0116934
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CHIP, a co-chaperone protein that interacts with Hsc/Hsp70, has been shown to be underexpressed in pancreatic cancer cells and has demonstrated a potential tumor suppressor property. Nevertheless, the underlying mechanisms of CHIP regulation in pancreatic cancer cells remain unknown. In this study, we found that miR-1178 decreased the translation of the CHIP protein by targeting the 30-UTR region. We observed that over-expression of miR-1178 facilitated the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells. Conversely, the inhibition of miR-1178 expression significantly suppressed these phenotypes. Furthermore, CHIP over-expression abrogated miR-1178-induced cell proliferation and invasion. Our data suggest that miR-1178 acts as an oncomiR in pancreatic cancer cells by inhibiting CHIP expression.
引用
收藏
页数:12
相关论文
共 39 条
  • [1] [Anonymous], 2010, CANCER RES, DOI DOI 10.1158/1538-7445.AM10-5703
  • [2] Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
  • [3] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [4] C-terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration
    Choi, Ye Na
    Lee, Sun Kyung
    Seo, Tae Woong
    Lee, Ji Sun
    Yoo, Soon Ji
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (04) : 1060 - 1066
  • [5] Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?
    Chuong, Michael D.
    Boggs, Drexell H.
    Patel, Kruti N.
    Regine, William F.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (03) : 166 - 177
  • [6] Causes and consequences of microRNA dysregulation in cancer
    Croce, Carlo M.
    [J]. NATURE REVIEWS GENETICS, 2009, 10 (10) : 704 - 714
  • [7] A NEW HUMAN PANCREATIC-CARCINOMA CELL-LINE DEVELOPED FOR ADOPTIVE IMMUNOTHERAPY STUDIES WITH LYMPHOKINE-ACTIVATED KILLER CELLS IN NUDE-MICE
    DRUCKER, BJ
    MARINCOLA, FM
    SIAO, DY
    DONLON, TA
    BANGS, CD
    HOLDER, WD
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY, 1988, 24 (12): : 1179 - 1187
  • [8] CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α
    Fan, MY
    Park, A
    Nephew, KP
    [J]. MOLECULAR ENDOCRINOLOGY, 2005, 19 (12) : 2901 - 2914
  • [9] MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells
    Funamizu, Naotake
    Lacy, Curtis Ray
    Parpart, Sonya T.
    Takai, Atsushi
    Hiyoshi, Yukiharu
    Yanaga, Katsuhiko
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 725 - 734
  • [10] miR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression
    Guo, Junwei
    Ren, Fangli
    Wang, Yinyin
    Li, Shan
    Gao, Zhengrong
    Wang, Xiaoyan
    Ning, Hongxiu
    Wu, Jianguo
    Li, Yi
    Wang, Zhao
    Chim, Shek Man
    Xu, Jiake
    Chang, Zhijie
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) : 1607 - 1618